Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial

Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial

Abstract Background Amnestic mild cognitive impairment (aMCI) is often considered a precursor to Alzheimer’s disease (AD) and represents a key therapeutic target for early intervention of AD. However, no treatments have been approved for MCI at present. Our previous pilot study has shown that Kami G...

Full description

Bibliographic Details
Main Authors: Hee-Yeon Shin, Tae-Bin Yim, Hye-Min Heo, Geon-Ho Jahng, Seungwon Kwon, Seung-Yeon Cho, Seong-Uk Park, Woo-Sang Jung, Sang-Kwan Moon, Chang-Nam Ko, Jung-Mi Park
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Mild cognitive impairment (MCI)
Amnestic mild cognitive impairment (aMCI)
Kami Guibi-tang
Herbal medicine
Herbal formula
Korean medicine
Online Access:https://doi.org/10.1186/s12906-022-03805-9

Internet

https://doi.org/10.1186/s12906-022-03805-9

Similar Items